Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas.
Front Immunol
; 12: 653081, 2021.
Article
in En
| MEDLINE
| ID: mdl-33936075
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoma
/
Recombinant Fusion Proteins
/
Receptors, IgG
/
CD3 Complex
/
NK Cell Lectin-Like Receptor Subfamily K
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Front Immunol
Year:
2021
Document type:
Article